4-(4-hydroxy-3-methyl-phenyl)-4-oxo-butyric acid | 91541-03-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 4-(4-hydroxy-3-methyl-phenyl)-4-oxo-butyric acid
• 英文别名: 4-(4-Hydroxy-3-methyl-phenyl)-4-oxo-buttersaeure；4-(3-Methyl-4-hydroxyphenyl)-4-oxobutyric acid；4-(4-hydroxy-3-methylphenyl)-4-oxobutanoic acid
• CAS: 91541-03-6
• 化学式: C₁₁H₁₂O₄
• 分子量: 208.214
• InChiKey: RVDWUHPNGCQYRK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  74.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  4-(4-hydroxy-3-methyl-phenyl)-4-oxo-butyric acid 生成 4-(4-hydroxy-3-methyl-phenyl)-4-oxo-butyric acid methyl ester
  参考文献：
  名称：

  Raval; Bokil; Nargund, Journal of the University of Bombay, Science: Physical Sciences, Mathematics, Biological Sciences and Medicine, 1938, vol. 7/3, p. 184,187

  摘要：

  DOI：
• 作为产物：
  描述：

  2-甲基苯甲醚 在 三氯化铝 、 氢溴酸 、 溶剂黄146 作用下， 以 1,2-二氯乙烷 为溶剂， 生成 4-(4-hydroxy-3-methyl-phenyl)-4-oxo-butyric acid
  参考文献：
  名称：

  （βR *，γS *）-4-[[3-（4-乙酰基-3-羟基-2-丙基苯氧基）丙基]硫代]-γ-羟基-β-甲基苯丁酸钠的设计与合成：白三烯D4的选择性，口服活性受体拮抗剂。

  摘要：

  DOI：

  10.1021/jm00159a003

文献信息

• Pyridazinone derivatives, their preparation and use
  申请人：Sankyo Company Limited

  公开号：US04914093A1

  公开（公告）日：1990-04-03

  Compounds of formula (I): ##STR1## (wherein Q is oxygen or sulfur, the dotted line is a single or double bond, A is alkylene, and R.sup.1 -R.sup.5 are a variety of atoms or organic groups) have excellent ability to potentiate myocardial contractivity and a variety of other properties, and can be used to treat cardiac disorders.

  式(I)的化合物：##STR1##（其中Q是氧或硫，虚线是单键或双键，A是烷基，R.sup.1-R.sup.5是各种原子或有机基团）具有优异的增强心肌收缩能力和多种其他性质，可用于治疗心脏疾病。
• Use of leukotriene antagonists for producing cytoprotective pharmaceutical compositions and process for producing cytoprotective pharmaceutical compositions
  申请人：Merck & Co., Inc.

  公开号：EP0156233A2

  公开（公告）日：1985-10-02

  Leukotriene antagonists have been found to be useful for inducing cytoprotection via an unspecified mechanism. Specific therapeutic utilities include, erosive gastritis, erosive esophagitis, inflammatory bowel disease, and induced hemorrhagic gastric erosions such as those caused by indomethacin or ethanol. The leukotriene antagonists are used to produce cytoprotective pharmaceutical compositions. In a process for producing cytoprotective pharmaceutical compositions the leukotriene antagonists are incorporated into a corresponding composition in a cytoprotective effective amount.

  已发现白三烯拮抗剂可通过不明机制诱导细胞保护，具体的治疗用途包括侵蚀性胃炎、侵蚀性食管炎、炎症性肠病和诱发出血性胃糜烂，如由吲哚美辛或乙醇引起的胃糜烂。 白三烯拮抗剂可用于生产细胞保护药物组合物。 在生产细胞保护药物组合物的过程中，白三烯拮抗剂以细胞保护有效量加入相应的组合物中。
• Foodstuffs containing sweetness inhibiting agents and process for inhibiting the sweetness perception of a foodstuff
  申请人：GENERAL FOODS CORPORATION

  公开号：EP0156317A2

  公开（公告）日：1985-10-02

  @ Foodstuffs containing sweetness inhibitors having the general formula: wherein R7 is selected from the group consisting of hydrogen and C1-C3 alkyl, R. is selected from the group consisting of hydrogen and C1-C3 alkyl and wherein R9 is the group wherein R2, R3, R4, R. and R4 are independently selected from the group consisting of hydrogen, C1-C3 alkyl, C1-C3 alkoxy, C1-C2 hydroxyalkyl, hydroxy and COOH; and the non-toxic salts thereof. Disclosed is also a process for inhibiting the sweetness perception of a foodstuff.

  其中R7选自由氢和C1-C3烷基组成的组，R.选自由氢和C1-C3烷基组成的组，R9是R2、R3、R4、R.和R4独立地选自由氢、C1-C3烷基、C1-C3烷氧基、C1-C2羟烷基、羟基和COOH组成的组，以及它们的无毒盐。 还公开了一种抑制食品甜味感知的工艺。
• Leukotriene antagonists
  申请人：MERCK FROSST CANADA INC.

  公开号：EP0252639A1

  公开（公告）日：1988-01-13

  Compounds of the Formulae: and are antagonists of leukotrienes of C4, D4 and E4, the slow reacting substance of anaphylaxis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents.

  这些化合物可用作抗哮喘、抗过敏、抗炎和细胞保护剂。
• Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
  申请人：BIORESEARCH, INC.

  公开号：EP0727149A2

  公开（公告）日：1996-08-21

  Sweetness inhibitors which are substantially tasteless have been found to be bitter taste inhibitors or blockers. Conversely, bitter taste inhibitors which are substantially tasteless have been found to be sweet taste inhibitors or blockers.

  已发现基本上无味的甜味抑制剂是苦味抑制剂或阻断剂。反之，基本无味的苦味抑制剂被发现是甜味抑制剂或阻断剂。